Today's Low
₹ 4.27
Today's High
₹ 4.42
52 Weeks Low
₹ 3.00
52 Weeks High
₹ 6.85
Lower
₹ 3.49
Upper
₹ 5.24
Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|
Total Current Assets | 215.5 | 118.8 | 122.3 |
Total Non-Current Assets | 226.9 | 198.9 | 27.3 |
Total Assets | 455.1 | 321.4 | 149.7 |
Total Current Liabilities | 107.4 | 105.3 | 66.6 |
Total Non-Current Liabilities | 14.1 | 16.5 | 16.4 |
Shareholder's Funds | 331.3 | 199.4 | 66.7 |
Total Liabilities | 455.1 | 321.4 | 149.7 |
The Industry Debt to Equity Ratio stands at 0.35, vs the Debt to Equity Ratio of 0.09, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.70, vs the Quick Ratio of 1.89, which results in a Positive aspect.
The Industry Current Ratio stands at 2.14, vs the Current Ratio of 2.01, which results in a Negative aspect.
The Industry Price to BV stands at 2.30, vs the Price to BV of 1.47, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|
Total Income | 476.1 | 300.9 | 75.0 |
Total Expenditure | 496.0 | 301.9 | 67.2 |
Operating Profit(Excl OI) | -16.1 | 42.7 | 8.8 |
Add: Other Income | 3.9 | 43.7 | 1.0 |
Operating Profit | -16.1 | 42.7 | 8.8 |
Less: Interest | 2.3 | 2.2 | 5.4 |
PBDT | -18.4 | 40.6 | 3.4 |
Less: Depreciation Amortization | 3.0 | 1.5 | 0.7 |
PBT & Exceptional Items | -21.4 | 39.1 | 2.8 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | -4.3 |
Profit Before Tax | -21.4 | 39.1 | -1.5 |
Less: Taxation | -5.9 | 10.1 | 2.0 |
Profit After Tax | -15.5 | 29.0 | -3.5 |
Earnings Per Share | 0.0 | 0.0 | 0.0 |
The Industry PAT Margin stands at 4.34, vs the PAT Margin of -3.26, which results in a Negative aspect.
The Industry PAT Growth stands at 95.83, vs the PAT Growth of -153.58, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.44, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 11.94, vs the PE Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Profit Before Tax | 24.0 | -21.4 | 39.1 | -1.5 |
Tax Paid | -1.8 | -0.6 | -0.2 | -0.7 |
Adjustment | -20.4 | 34.9 | -38.7 | 9.3 |
Changes In Working Capital | 24.0 | -21.4 | 39.1 | -1.5 |
Cash Flow after changes in Working Capital | -39.9 | -111.6 | -14.7 | -7.0 |
Cash Flow from Operating Activities | -41.7 | -112.2 | -14.9 | -7.7 |
Cash Flow from Investing Activities | -90.6 | -36.6 | -38.5 | 11.9 |
Cash Flow from Financing Activities | 136.6 | 150.6 | 59.1 | -4.3 |
Net Cash Inflow / Outflow | 4.2 | 1.7 | 5.7 | 0.0 |
Opening Cash & Cash Equivalents | 9.6 | 7.7 | 0.2 | 0.2 |
Closing Cash & Cash Equivalent | 13.8 | 9.6 | 7.7 | 0.2 |
The Industry PFCF Ratio stands at -46.67, vs the PFCF Ratio of -3.13, which results in a Positive aspect.
The Industry PCF RATIO stands at 0.59, vs the PCF RATIO of -4.33, which results in a Negative aspect.
Particulars | Sep 2024 | Jun 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1,348.8 | 920.9 | 992.8 | 1,160.3 | 988.9 | 1,181.0 | 1,339.5 | 1,318.1 | 922.0 | 1,025.9 | 1,067.4 | 674.9 |
Total Income | 1,382.3 | 943.3 | 1,023.7 | 1,227.4 | 1,105.1 | 862.6 | 1,345.8 | 1,330.4 | 943.0 | 1,333.8 | 1,141.1 | 717.7 |
Total Expenditure | 1,345.1 | 923.4 | 1,040.8 | 1,135.4 | 962.3 | 1,168.0 | 1,293.7 | 1,272.3 | 908.9 | 1,004.4 | 1,098.6 | 682.2 |
PBIDT (Excl OI) | 3.7 | -2.4 | -48.0 | 24.9 | 26.6 | 13.0 | 45.7 | 45.8 | 13.1 | 21.5 | -31.2 | -7.3 |
Other Income | 33.5 | 22.4 | 31.0 | 67.1 | 116.2 | -318.4 | 6.4 | 12.3 | 21.1 | 307.9 | 73.7 | 42.8 |
Operating Profit | 37.2 | 20.0 | -17.0 | 92.0 | 142.8 | -305.4 | 52.1 | 58.2 | 34.2 | 329.4 | 42.5 | 35.5 |
Interest | 10.3 | 6.6 | 5.6 | 6.7 | 5.0 | 12.1 | 5.2 | 2.8 | 2.9 | 4.5 | 2.5 | 1.2 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 26.8 | 13.4 | -22.6 | 85.3 | 137.9 | -317.5 | 46.9 | 55.3 | 31.2 | 324.9 | 39.9 | 34.3 |
Depreciation | 18.5 | 13.1 | 7.5 | 7.2 | 8.7 | 6.6 | 12.2 | 4.5 | 6.8 | 8.2 | 1.2 | 3.6 |
Profit Before Tax | 8.4 | 0.3 | -30.1 | 78.1 | 129.1 | -324.0 | 34.8 | 50.8 | 24.4 | 316.7 | 38.8 | 30.6 |
Tax | -30.1 | 29.5 | 8.6 | 1.6 | 12.2 | -55.4 | -27.1 | 25.8 | -1.8 | 85.3 | 10.0 | 5.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 38.4 | -29.2 | -38.7 | 76.5 | 117.0 | -268.6 | 61.9 | 25.0 | 26.2 | 231.4 | 28.8 | 25.6 |
Net Profit | 38.4 | -29.2 | -38.7 | 76.5 | 117.0 | -268.6 | 61.9 | 25.0 | 26.2 | 231.4 | 28.8 | 25.6 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 1,859.8 | 1,859.8 | 1,439.1 | 1,439.1 | 1,439.1 | 1,439.1 | 1,331.2 | 1,331.2 | 1,227.1 | 1,097.8 | 999.7 | 928.9 |
Reserves | 3,574.5 | 0.0 | 0.0 | 2,052.1 | 0.0 | 1,873.7 | 3,084.2 | 1,732.8 | 925.6 | 0.0 | 466.8 | 438.6 |
EPS | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | -0.2 | 0.1 | 0.0 | 0.2 | 0.3 | 0.0 | 0.0 |
Operating Profit Margin | 2.8 | 2.2 | -1.7 | 7.9 | 14.4 | -25.9 | 3.9 | 4.4 | 3.7 | 32.1 | 4.0 | 5.3 |
Net Profit Margin | 2.8 | -3.2 | -3.9 | 6.6 | 11.8 | -22.7 | 4.6 | 1.9 | 2.8 | 22.6 | 2.7 | 3.8 |
The Industry Mcap Growth stands at 152.08, vs the Mcap Growth of -17.12, which results in a Negative aspect.
The Industry Net Sales Growth stands at 54.29, vs the Net Sales Growth of 58.20, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 4.60 | 4.77 | 4.38 |
R3 | 4.54 | 4.53 | 4.34 |
R2 | 4.48 | 4.47 | 4.33 |
R1 | 4.39 | 4.38 | 4.31 |
Pivot | 4.33 | 4.32 | 4.33 |
S1 | 4.24 | 4.23 | 4.29 |
S2 | 4.18 | 4.17 | 4.27 |
S3 | 4.09 | 4.08 | 4.26 |
S4 | 4.00 | 3.87 | 4.22 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
0.00
Bullish
RSI
23.19
Bullish
ROC
-4.66
Bearish
UltimateOscillator
24.55
Bearish
Williams Indicator
-74.14
Neutral
CCI Indicator
-62.90
Neutral
MACD
-2,939.52
Bearish
Stochastic Indicator
29.52
Neutral
ATR
0.28
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
20-12-2024 | Inter-alia, to consider issuance of securities, in order to further augment the long-term resources of the Company, subject to all statutory approvals, and to appoint intermediaries for this purpose and to amend the Capital Clause of the Memorandum of the Company; |
22-10-2024 | Quarterly Results |
13-02-2024 | Quarterly Results |
17-10-2023 | Quarterly Results |
06-09-2023 | Preferential Issue of shares |
31-08-2023 | Preferential Issue of shares |
12-08-2023 | Quarterly Results |
23-05-2023 | Increase in Authorised Capital (Revised) & Audited Results The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023 The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023 |
19-05-2023 | Audited Results |
25-01-2023 | Quarterly Results & Inter alia,to consider, review and evaluate the progress in various businesses, strategies and their recent developments, and to consider and evaluate certain new business opportunities which could advantageously be combined with the Company's existing line of business and competencies, and all other matters connected therewith and incidental thereto. |
21-10-2022 | Quarterly Results |
03-09-2022 | A.G.M. |
25-07-2022 | Quarterly Results |
28-05-2022 | Audited Results |
15-02-2022 | General Purpose |
10-01-2022 | Quarterly Results |
26-10-2021 | Rights Issue |
14-10-2021 | Quarterly Results |
25-08-2021 | Rights Issue & Inter-alia,: i. to consider increase in Authorized Share Capital of the Company and consequent alteration in ?Capital Clause? of the Memorandum of Association of the Company to accommodate the further issuance of share; ii. to consider alteration of Article of Association of the Company to align the same with the existing business requirement of the Company and other applicable provisions; iii. to consider the proposal for acquisition of Advik Laboratories Limited through floating an Open Offer / an SPA (Special Purpose Agreement). iv. to consider the various proposals to select and appoint a professional technocommercial agency to guide the Ethanol project through the various statutory processes, registrations, approvals and for the ground work for establishment of the project. v. to consider the proposal for procurement of 2 land chunks measuring 15.6 Acres and 25 Acres respectively, valued at a total Rs 390 Million at Naurangpura, Kothputli, Rajasthan for the various activities of the Agri Business Division including Crop Storage & Preservation, Crop Research and Development and Cultivation. vi. to consider fund raising upto Rs. 50 Crores by way issuance of equity share of the company, partly paid up or fully paid-up, in one or more trenches, on Right Basis to the existing shareholders of the Company; vii. to fix the date, time, venue, mode of convening the 26th Annual General Meeting (?AGM?) of the company and approve notice calling the AGM along with Directors Report, secretarial Audit Report, corporate Governance Report with certificates and other matters/items incidental thereto; viii. to consider and approve the appointment of KMPs, Directors, if any; and ix. any other matter, with the permission of the Chair. |
19-07-2021 | Inter alia, to consider and approve review the status of company?s ongoing debt reduction program and other agendas. |
09-07-2021 | Quarterly Results |
25-06-2021 | Audited Results |
17-05-2021 | Right Issue of Equity Shares |